Clinical Trials Related to Solid Tumors

Related studies linked through entity extraction aliases.

Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Status: RECRUITING
Phase: PHASE2

Mobile Sensor Technologies to Assess General Symptomology of People With Cancer

Status: COMPLETED
Phase: N/A

Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain

Status: COMPLETED
Phase: N/A

A Study of DF6002 Alone and in Combination With Nivolumab

Status: COMPLETED
Phase: PHASE1

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

Status: SUSPENDED
Phase: PHASE1

A Study of TAK-102 in Adult With Previously-Treated Solid Tumors

Status: TERMINATED
Phase: PHASE1

A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors.

Status: COMPLETED
Phase: PHASE1

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Status: TERMINATED
Phase: PHASE1

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Status: COMPLETED
Phase: PHASE1

Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors

Status: WITHDRAWN
Phase: PHASE1/PHASE2

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Status: COMPLETED
Phase: PHASE1

KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Status: TERMINATED
Phase: EARLY_PHASE1

A Study of RC98 in Subjects With Advanced Malignant Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body

Status: COMPLETED
Phase: PHASE1

Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)

Status: COMPLETED
Phase: PHASE2